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Results: Figure 1 displays the results of binary logit regres-
sion. While survival was similar in RFA and Resection at 1 y,
at 3 y RFA fared worse. Elevated AFP and age were not
significant at 1 y, but were associated with increased odds of
death at 3 y. No assumptions of general linear models were
found to be violated. No influential outlier groups were seen.
Conclusion: Researchers are seeking ways to facilitate
resection and RFA in HCC. Studies have been published
discussing RFA and margins <1 cm for HCC up to 5 cm’s in
size. RFA probes have been shown to produce a cavity size of
4.5 cm’s in diameter. Although 3.5 cm was the largest tumor
size in our study, three year outcomes of RFA were signifi-
cantly inferior to resection and transplantation, reaching
almost twice the odds of death.
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LO-C.01 SPLIT-LIVER
TRANSPLANTATION: REPORT OF
RIGHT AND LEFT GRAFTS OUTCOMES
FROM A MULTICENTER ARGENTINEAN
GROUP
E. Halac1, M. Dip1, F. Alvarez2, J. Leiva Espinoza2,
E. Quinonez3,4, P. Romero 7, F. Nievas5, R. Maurette6,
C. Luque8, D. Matus1, P. Surraco1, M. Fauda5,6,
G. Gondolesi7, L. McCormack3, J. Mattera2,4,
O. Imventarza1
1Hospital Nacional De PediatrJuan P Garrahan, CABA,
CABA; 2Hospital Italiano De Buenos Aires, CABA, CABA;
3Hospital Aleman, CABA, CABA; 4Hospital El Cruce Dr.
Nestor Carlos Kirchner, Florencio Varela, BUENOS
AIRES; 5Hospital Universitario Austral, Derqui, BUENOS
AIRES; 6Hospital Britanico, CABA, CABA; 7Fundacion
Favaloro, CABA, CABA; 8Hospital General De Ninos Dr
Ricardo Gutierrez, CABA, CABA
Grafts from split livers constitute an accepted approach to
expand the donor pool. There was a significant interest from
most of the Argentinean centers to increase in the use of this
technique over the last 5 years.
Aims: Describe and analyze the outcomes of right (RSG)
and left (LSG) grafts from a multicenter study.
Methods: Multicenter retrospective study including data
from 111 recipients of split liver grafts between 1/1/2009–
31/12/2013. Incidence of surgical complications, patient and
graft survival, and factors that affected RSG and LSG sur-
vival were analyzed.
Results: Grafts types were 57 LSG and 54 RSG. Median
follow up times for LSG and RSG were 46 and 42 months
respectively. The 36-month patient and graft survivals for
LSG were 83% and 79%, and for RSG was 78% and 69%
respectively. Retrasplantation rates for LSG and RSG were
3.5% and 11% respectively. Artherial complications were the
most common cause of early retransplantation (less than 12
months). Cold ischemia time (CIT) longer than 10 hours and
the use of high risk donors (older than 40 years or BMI ≥30
or ≥5 days ICU) were independent factors for diminished
graft survival in RSG. No analyzed variables were associated
with worse graft survival in LSG. Biliary complications were
the most frequent in both groups(57% in LSG and 33% in
RSG).
Conclusions: Partial grafts obtained from liver splitting are
an excellent option for patients in need of liver transplanta-
tion, and have the potential to alleviate the organ shortage.
Adequate donor selection and reducing CIT are crucial for
optimizing results.
LO-C.02 INTRAOPERATIVE
HYPOTENSION DURING LIVER
TRANSPLANTATION IS ASSOCIATED
WITH DECREASED ONE YEAR PATIENT
AND GRAFT SURVIVAL
P. F. Sauer, D. A. DuBay, P. A. MacLennan,
J. H. Crawford, J. A. White, S. H. Gray, D. E. Eckhoff
University Of Alabama At Birmingham, Birmingham, AL
Introduction: Patients with end-stage liver disease experi-
ence peripheral vasodilatation and have lower mean arterial
blood pressure (MAP) at baseline. However, it is unclear how
intraoperative hypotension effects post-liver transplant
patient and graft survival. We hypothesized that increased
duration of MAP <60 mmHg (MAP <60) was associated
with decreased patient survival.
Methods: A retrospective study of adult liver transplant
patients from a single center was performed. Anesthesia
records were used to quantify the intraoperative duration of
MAP <60. Patients were stratified into 3 groups based on
cumulative duration MAP <60: <30 minutes, 30–59 minutes
and 60+ minutes. Blood product usage, length of hospitali-
zation, vasoactive drug administration, and 1-year patient
and graft survival were measured. MAP <60 duration groups
were compared using ANOVA, Chi-square tests, and Log-
Rank tests for continuous and categorical variables, and sur-
vival curves, respectively.
Results: Overall 565 patients were included: <30 minutes
(N = 461, 81.6%), 30–59 minutes (N = 42, 7.4%), and 60+
minutes (N = 62, 11.0%). Patients in the 60+ minutes group
had the highest MELD score (27.7, p = 0.0051), received
the most units of pRBCs (5.5, p < 0.0001), FFP (2.96,
p < 0.0001), platelets (1.5, p < 0.0001) and intravenous phe-
nylephrine (14487 μg, p < 0.0001), and had the lowest 1-year
patient (72.2%, p = 0.0060) and graft survival (72.2%,
p = 0.0063)(Table).
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Conclusion: Intraoperative hypotension, i.e., MAP <60, for
60+ minutes was associated with increased intraoperative
phenylephrine, blood product usage, and decreased 1-year
patient and graft survival. Surgical technique, anesthetic
management, and the avoidance of hypotension are critically
important for patient outcomes.
LO-C.03 A GLIMPSE INTO THE FUTURE:
DO WE KNOW WHAT INCREASING
NATIONALLY SHARED LIVER
ALLOGRAFTS WILL MEAN?
A. Ertel, K. Wima, R. Hoehn, D. Abbott, S. Shah
University Of Cincinnati Department Of Surgery,
Cincinnati, OHIO
Purpose: Due to the current geographic disparities in liver
allocation, a new policy endorsing broader sharing of liver
allografts has been proposed. In this model there will be a
substantial increase in the number of nationally shared,
deceased donor livers. We aimed to investigate the potential
ramifications this new policy may have on patient outcomes
and resource utilization following liver transplantation (LT).
Methods: The Scientific Registry of Transplant Recipients
(SRTR) was queried for all nationally shared LT from 2007–
2011 and linked to the University Health Consortium (UHC)
database (n = 12,445). Univariate analysis was used to deter-
mine how donor, recipient characteristics, clinical outcomes
and hospital resource utilization were associated with
national sharing as compared to local and regional sharing.
Results: Nationally shared livers have a higher donor risk
index (>1.8), and are more likely to be classified as expanded
criteria donors compared to regional and locally shared
livers. Recipients of nationally shared livers were more likely
to be independent, have lower MELD scores, and were less
likely to be hospitalized or severely limited at the time of
transplant. Nationally shared LTs were more likely to be
performed at high volume centers, resulted in higher trans-
plant hospitalization costs, in hospital mortality, and 30-day
readmissions (Table 1).
Conclusion: Nationally shared donor livers are of lesser
quality, and are being transplanted into healthier recipients.
Despite this, they have increased mortality, cost, and read-
mission rates. These data suggest that with the proposed
policy of broader sharing, patient outcomes will be impaired,
though require more hospital resources.
LO-C.04 SOCIETAL REINTEGRATION
FOLLOWING CADAVERIC LIVER
TRANSPLANTATION
R. P. Kelly, M. Molinari
Dalhousie University, Halifax, NS
Background: Data related to social reintegration following
Orthotopic liver transplantation (OLT) is lacking. For the
purpose of this study “social re-integration” was defined as:
the ability of an individual to return to the same marital,
educational, and financial status they held pre-OLT. The
primary aim of this study was to assess the rate of social
re-integration following OLT in Atlantic Canada.
Methods: Between September 2006 and January 2008
patients that were ≥3 years post OLT were included in this
prospective cohort study. Externally validated Question-
naires were self administered to those who participated. All
data was then prospectively collected. Categorical variables
were analyzed by Chi-Square or Fisher’s exact test and con-
tinuous variables by Student’s t-test.
Results: Among 157 eligible patients 110 (70%) partici-
pated. The mean age was 57 years (SD + 11.4). Prior to OLT,
75% were married and 6% were divorced. Following OLT
there was no significant difference in marital status. Employ-
ment rate fell from 72% pre-OLT to 30% post-OLT. Low-
skill employees were less likely to return to work post-OLT
compared to than those who were self-employed. Personal
income fell an average of $4,363 (SD + 20,733) (p = 0.03).
Nevertheless, 38% of patients reported improved earning
potential post-OLT. Overall, 80% of participants expressed
satisfaction for their role in society post-OLT.
Conclusion: Following OLT, few patients are able to fully
reintegrate into the positions and status held pre-OLT.
Employment status is most likely to be negatively affected
following OLT. These findings suggest that focused strat-
egies for preserving social status be implemented before and
after OLT.
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LO-C.05 DEFINING THE INFLUENCE OF
GENDER DISCORDANCE ON SURVIVAL
FOLLOWING LIVING DONOR LIVER
TRANSPLANTATION
J. T. Miura, A. Fathi, F. M. Johnston, S. Tsai,
K. K. Christians, K. K. Turaga, T. C. Gamblin
Medical College Of Wisconsin, Department Of Surgery,
Milwaukee, WI
Background: Donor-recipient gender discordance has been
suggested to be an independent predictor of poor outcomes
following deceased donor liver transplantation (DDLT).
Whether a similar trend occurs with living donor transplants
(LDLT) remains ill defined. The present study sought to
evaluate the association between gender mismatch and sur-
vival following LDLT.
Study Design: Patients that underwent LDLT were identi-
fied from the Organ Procurement and Transplant Network
database (2000–2012), and categorized by the following
donor-recipient gender groups: Female (F)/F, Male (M)/F,
M/M, and F/M. Log rank test and multivariable Cox propor-
tional hazards models were used to assess graft survival (GS)
and overall survival (OS) of the study groups.
Results: A total of 3,143 LDLT were identified: 731 F/F,
794 M/F, 1,015 M/M, and 603 F/M. Ten year GS and OS
were highest in the F/F group, at 62% and 71% respectively,
as compared to M/F (53%, 66%), M/M (55%,62%), and F/M
(55%,66%). Multivariate analysis demonstrated that gender
mismatch was not associated with poorer GS (MM: Refer-
ence; MF: HR 1.22, p = 0.06; FF: HR 1.02, p = 0.86; FM:
HR 1.18, p = 0.18). Independent factors associated with
poorer GS included older recipient age (HR: 1.01, 95% CI:
1.00–1.02; p = 0.01), increasing donor age (HR: 1.01,
95%CI: 1.00–1.02; p = 0.01), higher Model for End-stage
Liver Disease score (HR: 1.02, 95%CI: 1.01–1.04;
p = 0.003), and left lobe allografts (HR: 2.08, 95%CI: 1.55–
2.79; p < 0.001).
Conclusions: Donor-recipient gender discordance does not
impact both GS and OS following LDLT. Living donor organ
allocation in an era of supply limitation should not be influ-
enced by donor gender.
LO-C.06 RECCURRENT
HEPATOCELLULAR CANCER AFTER
LIVER TRANSPLANTION: THE ROLE OF
LIVER-DIRECTED THERAPY
V. Donchev, G. Voidonikolas, M. Sheckley, A. Annamalai,
I. Kim, A. Klein, A. Wachsman, M. Friedman,
S. Colquhoun, N. Nissen
Cedars-Sinai Medical Center, Los Angeles, CA
Introduction: Recurrence of hepatocellular cancer (HCC)
after liver transplant (LT) generally carries a poor prognosis.
We reviewed our experience to determine the role of liver-
directed treatments.
Methods: Retrospective review of 10-year single center
experience. All patients were within radiographic Milan cri-
teria for HCC at the time of LT. Of 201 patients undergoing
LT for HCC, 29 (14%) were identified with HCC recurrence.
Results: Mean and median time to recurrence after LT was
24 +/− 4 mo. and 15 mo. (range 3–160 mo.) respectively.
Explant pathology showed that most patients (26/29) had
pathologic staging exceeding Milan criteria. The initial
recurrence was liver-only in 7 patients (24%), liver-dominant
in 5 patients (17%) and systemic in 17 patients (59%). Time
to recurrence was greatest in the liver-only group at mean
34 mo., followed by mean 24 mo. in the liver-dominant
group and mean 14 mo. in systemic group. Patients with
liver-only or liver-dominant tumor underwent a total of 57
loco-regional treatments (range 1–14). There were 3 signifi-
cant treatment-related complications.
Survival: Mean survival after tumor recurrence in all
patients was 15 +/− 4 mo. The 1 and 3 year survival after
recurrence was 62% and 21% respectively. Patients undergo-
ing liver-directed therapy had improved survival compared to
the remainder of patients (25 mo. vs 14 mo., p < .05, figure).
Conclusions: HCC recurrence after LT is heterogeneous.
Almost all recurrences are in patients with poor explant
pathology. Aggressive liver-directed therapies are safe and
effective in patients with liver-dominant recurrence and can
lead to improved survival.
FRIDAY, MARCH 13, 2015,
4:30PM–6:30PM
LONG ORAL D – PANCREAS
PERIOPERATIVE/TECHNIQUES
LO-D.01 IMPROVED PERIOPERATIVE
OUTCOMES WITH EPIDURAL
ANALGESIA IN PATIENTS
UNDERGOING PANCREATECTOMY:
A NATIONWIDE ANALYSIS
D. E. Sanford, W. G. Hawkins, R. C. Fields
Washington University, St. Louis, MISSOURI
Background: Despite scant evidence demonstrating benefit,
epidural analgesia (EA) is often used for patients under-
going pancreatectomy. We sought to examine the impact
of epidural analgesia on postoperative outcomes after
pancreatectomy.
Methods: We used the 2008–2011 Healthcare Cost and Uti-
lization Project Nationwide Inpatient Sample to examine the
effect of EA on perioperative outcomes. Student’s t tests and
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